SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Over-Allotment Facility and Offer Update

10 Feb 2026 07:00

RNS Number : 3037S
Baronsmead Venture Trust PLC
10 February 2026
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

Baronsmead Venture Trust plc

LEI: 213800VQ1PQHOJXDDQ88

 

10 February 2026

Announcement of Intention to Utilise Over-Allotment Facility and Offer Update

The Board of Baronsmead Venture Trust plc (the "Company") announced on 13 October 2025 that the Company, together with Baronsmead Second Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise over-allotment facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer"). Full details of the Offer are contained in the Prospectus dated 13 October 2025.

The Board is pleased to announce that valid applications have been received for over £12 million under the Company's Offer and therefore the initial amount of £15 million is likely to be fully subscribed for shortly. Accordingly, based on investor demand, the Board announce that they intend to utilise the full Over-allotment Facility of up to £10 million in respect of the Company's Offer.

The first allotment of shares in respect of valid applications accepted by the Company took place on 20 November 2025. The next scheduled allotment date is 19 February 2026. As stated in the Prospectus, the final allotment will only take place if the Offer is not fully subscribed by 2 April 2026 and the Board decides to extend the period of the Offer.

All capitalised terms used and not defined herein shall have the same meaning as in the Prospectus.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

 

 

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 13 October 2025 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc, in connection with the Offer. A copy of the Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus. Potential investors are recommended to read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGWPUPQGQB
Date   Source Headline
2nd Dec 20194:42 pmRNSTotal Voting Rights
28th Nov 20194:35 pmRNSTransaction in Own Shares
25th Nov 20194:58 pmRNSDirector/PDMR Shareholding
25th Nov 20193:35 pmRNSPublication of Suppl.Prospcts
25th Nov 20197:00 amRNSAnnual Financial Report for the y/e 30/09/2019
20th Nov 201912:31 pmRNSIssue of New Shares
6th Nov 20195:40 pmRNSPDMR Shareholding
6th Nov 20195:15 pmRNSNet Asset Value(s)
1st Nov 201911:41 amRNSTotal Voting Rights
11th Oct 20194:00 pmRNSNet Asset Value(s)
10th Oct 20195:37 pmRNSTransaction in Own Shares
4th Oct 20199:00 amRNSPublication of a Prospectus
1st Oct 20195:53 pmRNSTotal Voting Rights
30th Sep 20195:31 pmRNSDirector/PDMR Shareholding
27th Sep 20194:27 pmRNSTransaction in Own Shares
23rd Sep 201912:00 pmRNSDividend Policy Change Announcement
5th Sep 201910:15 amRNSNet Asset Value(s)
8th Aug 20194:00 pmRNSDividend Declaration
8th Aug 20194:00 pmRNSIntention to Fundraise
6th Aug 20193:00 pmRNSNet Asset Value(s)
1st Aug 20195:31 pmRNSTotal Voting Rights
30th Jul 20195:23 pmRNSTransaction in Own Shares
10th Jul 20195:45 pmRNSNet Asset Value(s)
1st Jul 201911:40 amRNSTotal Voting Rights
27th Jun 20195:22 pmRNSDirector/PDMR Shareholding
27th Jun 20195:04 pmRNSTransaction in Own Shares
6th Jun 20195:20 pmRNSNet Asset Value(s)
3rd Jun 20197:00 amRNSTotal Voting Rights
29th May 20195:36 pmRNSTransaction in Own Shares
23rd May 20199:00 amRNSHalf-year Report
7th May 201910:30 amRNSNet Asset Value(s)
12th Apr 20194:00 pmRNSNet Asset Value(s)
2nd Apr 20195:39 pmRNSDirector/PDMR Shareholding
1st Apr 20192:42 pmRNSTotal Voting Rights
28th Mar 20194:56 pmRNSTransaction in Own Shares
12th Mar 20193:02 pmRNSDirector/PDMR Shareholding
8th Mar 201910:30 amRNSReplacement Transaction in Own Shares
7th Mar 20195:22 pmRNSTransaction in Own Shares
5th Mar 20194:00 pmRNSNet Asset Value(s)
1st Mar 201912:10 pmRNSTotal Voting Rights
27th Feb 20194:44 pmRNSResult of AGM
12th Feb 201912:43 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20194:13 pmRNSDirector/PDMR Shareholding
7th Feb 20191:00 pmRNSIssue of New Shares
5th Feb 201910:45 amRNSNet Asset Value(s)
24th Jan 201911:30 amRNSNet Asset Value(s)
18th Jan 20192:57 pmRNSOffer for Subscription - Update
9th Jan 20199:00 amRNSPublication of a Prospectus
2nd Jan 201911:47 amRNSTotal Voting Rights
21st Dec 20185:24 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.